Q Fever in Pregnancy—Case Presentation and Literature Review

Kugler Eitan, Amital Howard, Alon Danny

Rabin Medical Center, Beilinson Hospital, Department of Medicine B, Petah Tikva, Israel.
Rabin Medical Center, Beilinson Hospital, Department of Medicine F, Petah Tikva, Israel.
Sheba Medical Center, Department of Medicine B, Tel Hashomer, Israel.

DOI: 10.4236/ijcm.2013.48065                

Abstract

Q fever is a widespread zoonotic infection caused by Coxiella burnetii. During acute infection, three clinical patterns are commonly encountered—self limited, flu like disease, atypical pneumonia or hepatits. Chronic infection almost always implies endocarditis. Acute infection during pregnancy may result in obstetrical complications, and predispose to chronic transformation. Treatment during pregnancy is more complex, and the duration of treatment was debatable up until recently. We describe a 31 years old patient with acute Q fever infection during pregnancy. We review the medical treatment, complications and follow up of acute and chronic Q fever during pregnancy.

Keywords

Q Fever; Coxiella burnetii; Pregnancy

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	E. H. Derrick, “‘Q’ Fever, a New Fever Entity: Clinical Features, Diagnosis and Laboratory Investigation,” Medical Journal of Australia, Vol. 2, 1937, pp. 281-229.
[2]	D. Raoult, et al., “Q Fever 1985-1998. Clinical and Epidemiologic Features of 1383 Infections,” Medicine (Baltimore), Vol. 79, No. 2, 2000, pp. 109-123. doi:10.1097/00005792-200003000-00005
[3]	D. Raoult and T. Marrie, “Q Fever,” Clinical Infectious Diseases, Vol. 20, No. 3, 1995, p. 489. doi:10.1093/clinids/20.3.489
[4]	F. Fenollar, P. E. Fournier, M. P. Carrieri, G. Habib, T. Messana and D. Raoult, “Risks Factors and Prevention of Q Fever Endocarditis,” Clinical Infectious Diseases, Vol. 33, No. 3, 2001, pp. 312-316. doi:10.1086/321889
[5]	D. Raoult and F. Fenollar, “Stein A. Q Fever during Pregnancy: Diagnosis, Treatment, and Follow-Up,” Archives of Internal Medicine, Vol. 162, No. 6, 2002, pp. 701-704. doi:10.1001/archinte.162.6.701
[6]	H. Tissot-Dupont, V. Vaillant, S. Rey and D. Raoult, “Role of Sex, Age, Previous Valve Lesion, and Pregnancy in the Clinical Expression and Outcome of Q Fever after a Large Outbreak,” Clinical Infectious Diseases, Vol. 44, No. 2, 2007, pp. 232-237. doi:10.1086/510389
[7]	X. Carcopino, D. Raoult, F. Bretelle, L. Boubli and A. Stein, “Managing Q Fever during Pregnancy: The Benefits of Long-Term Cotrimoxazole Therapy,” Clinical Infectious Diseases, Vol. 45, No. 5, 2007, pp. 548-555. doi:10.1086/520661
[8]	A. Kumar, M. P. Yadav and S. Kakkar, “Human Milk as a Source of Q-Fever Infection in Breast-Fed Babies,” Indian Journal of Medical Research, Vol. 73, 1981, pp. 510-512.
[9]	B. N. Prasad, N. K. Chandiramani and A. Wagle, “Isolation of Coxiellaburnetii from Human Sources,” International Journal of Zoonoses, Vol. 13, No. 2, 1986, pp. 112-117.
[10]	A. Stein and D. Raoult, “Q Fever during Pregnancy: A Public Health Problem in Southern France,” Clinical Infectious Diseases, Vol. 27, No. 3, 1998, pp. 592-596. doi:10.1086/514698
[11]	D. Raoult and D. Stein, “Q Fever during Pregnancy: A Risk for Women, Fetuses, and Obstetricians [Letter],” The New England Journal of Medicine, Vol. 330, No. 5, 1994, p. 371. doi:10.1056/NEJM199402033300518
[12]	J. Denman and M. Woods, “Acute Q Fever in Pregnancy: Report and Literature Review,” Internal Medicine Journal, Vol. 39, 2009, pp. 479-484. doi:10.1111/j.1445-5994.2009.01933.x
[13]	W. A. Ray, et al., “Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes,” The New England Journal of Medicine, Vol. 351, No. 11, 2004, p. 1089. doi:10.1056/NEJMoa040582
[14]	A. Boulos, et al., “Measurement of the Antibiotic Susceptibility of Coxiella burnetii Using Real Time PCR,” International Journal of Antimicrobial Agents, Vol. 23, No. 2, 2004, p. 169. doi:10.1016/j.ijantimicag.2003.07.007
[15]	A. Gikas, et al., “Newer Macrolides as Empiric Treatment for Acute Q Fever Infection,” Antimicrobial Agents and Chemotherapy, Vol. 45, No. 12, 2001, p. 3644. doi:10.1128/AAC.45.12.3644-3646.2001